J. Liang

The potential mechanism for the effect of heparin on tissue plasminogen activator-mediated plasminogen activation.

V. Yang, Y. Li, J. Liang, 2000, Thrombosis research.

Biomedical application of immobilized enzymes.

V. Yang, J F Liang, Y T Li, 2000, Journal of pharmaceutical sciences.

Improved gene expression using low molecular weight peptides produced from protamine sulfate

K. A. Friedman, R. Kharidia, K. Friedman, 2008, Biochemistry (Moscow).

Receptor-ligand affinity-based screening and isolation of water-soluble 5-lipoxygenase inhibitors from Phellinus igniarius.

Xu Zhou, Yuchi Zhang, Chunming Liu, 2022, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

ATTEMPTS: a heparin/protamine-based delivery system for enzyme drugs.

V. Yang, S. Naik, Y. Park, 2002, Journal of controlled release : official journal of the Controlled Release Society.

A Less Toxic Heparin Antagonist—Low Molecular Weight Protamine

V. Yang, L.-C. Chang, J. Liang, 2004, Biochemistry (Moscow).

A novel heparin/protamine-based pro-drug type delivery system for protease drugs.

V. Yang, H. Song, Y. Li, 2000, Journal of pharmaceutical sciences.

Reduced reactivity towards anti-protamine antibodies of a low molecular weight protamine analogue.

V. Yang, V. K. Singh, B. Tsui, 2001, Thrombosis research.

ATTEMPTS: a heparin/protamine-based prodrug approach for delivery of thrombolytic drugs.

V. Yang, J. F. Liang, Y. Park, 2001, Journal of controlled release : official journal of the Controlled Release Society.